Thermo Fisher to sell three analytical divisions to GE Healthcare


Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.

GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.


Related Content

Business roundup

28 October 2009 Business

news image

Industry news, November 2009

Thermo Fisher to buy Life Technologies in $15.8bn deal

19 April 2013 Business

news image

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

Smart skin for prosthetic limbs senses heat and touch

12 December 2014 Research

news image

Ultra-thin plastic skin can bend and flex without affecting the skin's ability to detect stimuli

Chemistry behind the ‘blue man’ unlocked

1 November 2012 Research

news image

Biochemical model suggests that silver ions, not nanoparticles, cause a rare skin complaint